METACARE Co., Ltd.
Financials
Valuation Metrics
METACARE Co., Ltd.'s Market Cap is ₩285B. At end of 2025 it was ₩673B. Ranked #2099 of 2,436 in KR market (top 86%), #760 of 787 on KOSPI (top 97%), #87 of 96 in Health Care Equipment & Services (top 91%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 28.54B KRW | KR#2,099/2,436 Sec#87/96 |
| Revenue | 36.95B KRW | KR#1,940/2,436 Sec#58/96 |
| Net Income | 455.3M KRW | KR#1,468/2,436 Sec#48/96 |
| Total Assets | 188.61B KRW | KR#1,317/2,436 Sec#38/96 |
| Net Assets | 121.63B KRW | KR#1,268/2,436 Sec#37/96 |
| Employees | 21 | KR#2,222/2,436 Sec#85/96 |
| Value | ||
| P/E | 62.68x | KR#1,384/2,436 Sec#45/96 |
| P/B | 0.23x | KR#182/2,436 Sec#2/96 |
| P/S | 0.77x | KR#1,217/2,436 Sec#17/96 |
| EV/EBITDA | 57.21x | KR#1,378/2,436 Sec#44/96 |
| FCF Yield | -0.86% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | 0.37% | KR#1,473/2,436 Sec#48/96 |
| ROA | 0.24% | KR#1,454/2,436 Sec#47/96 |
| Op. Margin | 3.70% | KR#1,107/2,436 Sec#46/96 |
| Revenue Growth | 68.83% | KR#208/2,436 Sec#8/96 |
| Financial Health | ||
| Debt Ratio | 155.07% | KR#1,257/2,436 Sec#68/96 |
| Total Debt | 52.29B KRW | KR#970/2,436 Sec#24/96 |
| FCF | -245.3M KRW | KR#1,236/2,436 Sec#35/96 |
| Cash | 2.55B KRW | KR#2,198/2,436 Sec#89/96 |
| Current Ratio | 0.32x | KR#2,321/2,436 Sec#94/96 |
| Net Debt/EBITDA | 36.35x | KR#1,504/2,436 Sec#50/96 |
| Performance | ||
| 1Y Return | -61.26% | KR#2,252/2,436 Sec#85/96 |
| 1M Return | 5.12% | KR#466/2,436 Sec#23/96 |
| From 52W High | -68.36% | KR#2,080/2,436 Sec#76/96 |
| 1Y MDD | -69.47% | KR#1,929/2,436 Sec#71/96 |
| Trading | ||
| Volume | 9,110 shares | KR#2,146/2,436 Sec#88/96 |
| Foreign Own. | 1.85% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | 54 KRW | KR#1,442/2,436 Sec#46/96 |
| BPS | 6,977 KRW | KR#1,187/2,436 Sec#27/96 |
Company Info
This company was established in 2009, spun off from Woori Pharmacy's Medical Business Division. In 2024, it expanded its real estate business by acquiring Metaprime and added medical service consulting through the acquisition of Momo Labs. Meta Care provides services including the distribution of pharmaceuticals and medical devices, rental and management of non-residential buildings, and management consulting for hair transplant specialty hospitals. It is expanding its healthcare infrastructure through urban leasing projects and pursuing co-growth through partnerships with hair transplant hospitals. Meta Care was founded in 2009 and is headquartered in Hwaseong-si, Gyeonggi-do.